Journal profile · Endocrinology & Metabolism
Journal of Diabetes and its Complications
ISSN 1056-8727 · eISSN 1873-460X · Elsevier Inc. · UNITED STATES · Bimonthly · Founded 1992
Journal of Diabetes and its Complications: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.18; hybrid open access; APC about USD 3,760; median 107 days to acceptance (100 articles, last 24 months); community-reported acceptance: fairly easy; 185 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Diabetes and its Complications is published by Elsevier Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management and Diabetes Management and Research, together about 30.9% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Diabetes and Its Complications (JDC) is a journal for health care practitioners and researchers. JDC aims to act as a source of information usable by diabetes practitioners and researchers to increase their knowledge about mechanisms of diabetes and complications development. Journal of Diabetes and Its Complications also aims to promote better management of people with diabetes who are at risk for those complications. JDC publishes original research about the pathogenesis, diagnosis and management of diabetes mellitus and its complications as well as articles on physiological and molecular aspects of glucose homeostasis.Manuscripts submitted to JDC can report any aspect of basic, translational or clinical research as well as epidemiology.Topics can range broadly from early prediabetes to late-stage complicated diabetes.The journal publishes topics relevant to basic/translational reports including:pancreatic islet dysfunction and insulin resistancealtered adipose tissue function in diabetesaltered neuronal control of glucose homeostasismechanisms of drug actionAnd also topics relevant to diabetic complications including:diabetic retinopathyneuropathynephropathyperipheral vascular diseasecoronary heart diseasegastrointestinal disordersrenal failureimpotencehypertensionhyperlipidemia
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Manfredi RizzoPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 28, Italy 7, Ukraine 4, Türkiye 2, United Arab Emirates 2 (57 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine10.6%
- Diabetes Treatment and ManagementMedicine10.2%
- Diabetes Management and ResearchMedicine10.1%
- Chronic Kidney Disease and DiabetesMedicine7.9%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology5.7%
- Diabetes Management and EducationMedicine4.3%
- Diabetic Foot Ulcer Assessment and ManagementMedicine4.2%
- Retinal Diseases and TreatmentsMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.18LetPub ·
- Impact factor (publisher)
- 3.2Publisher website ·
- CiteScore 2026-06
- 5.4LetPub ·
- CiteScore (publisher)
- 5.4Publisher website ·
- SJR 2026-06
- 1.06LetPub ·
- SNIP 2026-06
- 0.86LetPub ·
- h-index
- 77LetPub ·
- h-index
- 123OpenAlex ·
- i10-index
- 2,588OpenAlex ·
- 2-year mean citedness
- 3.4OpenAlex ·
- Self-citation rate
- 6.2%LetPub ·
- Share of gold OA articles
- 28.13%LetPub ·
Volume
- Articles per year
- 149LetPub ·
Articles by year OpenAlex count · 4,337 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 79 | 35 | 37 |
| 2025 | 185 | 74 | 506 |
| 2024 | 155 | 75 | 883 |
| 2023 | 158 | 56 | 1,390 |
| 2022 | 160 | 68 | 2,018 |
| 2021 | 174 | 61 | 2,513 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
107 daysMedian, submission to acceptance · P25–P75 75 days – 154 days
- Acceptance to online
- median 3 days (100 articles)
- Submission to online
- median 111 days
- Sample
- 100 articles with submission and acceptance dates (299 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- First decision after review
- 49 daysPublisher website ·
- Submission to acceptance
- 103 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,760 / EUR 3,520 / GBP 3,010 / JPY 466,350 | — | — | |
| Publisher website | USD 4,280 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 5,000 words
- Reference style
- AMA
- Highlights
- Optional
Article types accepted13, with length limits
- brief reportN.B. For reasons of available space, manuscripts that exceed the required word limits (below) will be declined automatically. All articles other than Editorials…main text ≤ 1,000 words
- brief reportsBrief Reports should not exceed 1000 words, including a summary of no more than 50 words (but not including up to 20 references) and may be a preliminary report…Length not stated
- commentariesCommentaries (1000 words not including a maximum of 20 references and one small figure) offer a stimulating, journalistic and accessible insight into issues of …Length not stated
- commentaryN.B. For reasons of available space, manuscripts that exceed the required word limits (below) will be declined automatically. All articles other than Editorials…main text ≤ 1,000 words
- editorialN.B. For reasons of available space, manuscripts that exceed the required word limits (below) will be declined automatically. All articles other than Editorials…main text ≤ 1,000 words
- editorialsEditorials are either written or commissioned by the Editors and should not exceed 1000 words (not including a maximum of 20 references; one small figure can be…Length not stated
- letters to the editorN.B. For reasons of available space, manuscripts that exceed the required word limits (below) will be declined automatically. All articles other than Editorials…Length not stated
- opinionN.B. For reasons of available space, manuscripts that exceed the required word limits (below) will be declined automatically. All articles other than Editorials…Length not stated
- original research articleN.B. For reasons of available space, manuscripts that exceed the required word limits (below) will be declined automatically. All articles other than Editorials…main text ≤ 5,000 words
- original research articlesOriginal Research Articles should be a maximum of 5000 words.Length not stated
- reviewN.B. For reasons of available space, manuscripts that exceed the required word limits (below) will be declined automatically. All articles other than Editorials…Length not stated
- review articleN.B. For reasons of available space, manuscripts that exceed the required word limits (below) will be declined automatically. All articles other than Editorials…main text ≤ 5,000 words
- review articlesReview articles should be a maximum of 5000 words, including a summary of no more than 200 words (not including up to 75 references) with subheadings in the tex…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1992
- ISSN
- 1056-8727
- Electronic ISSN
- 1873-460X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Diabetes and its Complications
What CAS zone is Journal of Diabetes and its Complications in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Diabetes and its Complications is in Zone 3 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Diabetes and its Complications?
The latest impact factor listed by LetPub is 3.18; CiteScore 5.4, h-index 123.
How long does peer review take at Journal of Diabetes and its Complications?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 107 days (interquartile range 75–154 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Diabetes and its Complications?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 5,000 words; Reference style: AMA; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Diabetes and its Complications based?
Of the 57 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (28), Italy (7) and Ukraine (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Diabetes and its Complications?
According to LetPub and DOAJ records, Journal of Diabetes and its Complications is indexed in SCIE and Scopus.
Is Journal of Diabetes and its Complications open access, and what is the APC?
Journal of Diabetes and its Complications is a hybrid journal. For open-access publication: APC about USD 3,760.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .